Literature DB >> 23028042

Casein kinase 1α regulates an MDMX intramolecular interaction to stimulate p53 binding.

Shaofang Wu1, Lihong Chen, Andreas Becker, Ernst Schonbrunn, Jiandong Chen.   

Abstract

MDMX is an important regulator of p53 during embryonic development and malignant transformation. Previous studies showed that casein kinase 1α (CK1α) stably associates with MDMX, stimulates MDMX-p53 binding, and cooperates with MDMX to inactivate p53. However, the mechanism by which CK1α stimulates MDMX-p53 interaction remains unknown. Here, we present evidence that p53 binding by the MDMX N-terminal domain is inhibited by the central acidic region through an intramolecular interaction that competes for the p53 binding pocket. CK1α binding to the MDMX central domain and phosphorylation of S289 disrupts the intramolecular interaction, allowing the N terminus to bind p53 with increased affinity. After DNA damage, the MDMX-CK1α complex is disrupted by Chk2-mediated phosphorylation of MDMX at S367, leading to reduced MDMX-p53 binding. Therefore, CK1α is an important functional partner of MDMX. DNA damage activates p53 in part by disrupting CK1α-MDMX interaction and reducing MDMX-p53 binding affinity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23028042      PMCID: PMC3497597          DOI: 10.1128/MCB.00851-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  MDMX regulation of p53 response to ribosomal stress.

Authors:  Daniele M Gilkes; Lihong Chen; Jiandong Chen
Journal:  EMBO J       Date:  2006-11-16       Impact factor: 11.598

2.  Dual-site regulation of MDM2 E3-ubiquitin ligase activity.

Authors:  Maura Wallace; Erin Worrall; Susanne Pettersson; Ted R Hupp; Kathryn L Ball
Journal:  Mol Cell       Date:  2006-07-21       Impact factor: 17.970

3.  Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans.

Authors:  K Linke; P D Mace; C A Smith; D L Vaux; J Silke; C L Day
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

4.  A function for the RING finger domain in the allosteric control of MDM2 conformation and activity.

Authors:  Bartosz Wawrzynow; Susanne Pettersson; Alicja Zylicz; Janice Bramham; Erin Worrall; Ted R Hupp; Kathryn L Ball
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

5.  Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain.

Authors:  Grzegorz M Popowicz; Anna Czarna; Tad A Holak
Journal:  Cell Cycle       Date:  2008-05-27       Impact factor: 4.534

Review 6.  p53 in health and disease.

Authors:  Karen H Vousden; David P Lane
Journal:  Nat Rev Mol Cell Biol       Date:  2007-04       Impact factor: 94.444

7.  Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.

Authors:  Baoli Hu; Daniele M Gilkes; Jiandong Chen
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

8.  Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.

Authors:  Tamara Terzian; Yongxing Wang; Carolyn S Van Pelt; Neil F Box; Elisabeth L Travis; Guillermina Lozano
Journal:  Mol Cell Biol       Date:  2007-05-25       Impact factor: 4.272

9.  Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes.

Authors:  Joerg Kallen; Arnaud Goepfert; Anke Blechschmidt; Aude Izaac; Martin Geiser; Gisele Tavares; Paul Ramage; Pascal Furet; Keiichi Masuya; Joanna Lisztwan
Journal:  J Biol Chem       Date:  2009-01-19       Impact factor: 5.157

10.  Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX.

Authors:  Marzena Pazgier; Min Liu; Guozhang Zou; Weirong Yuan; Changqing Li; Chong Li; Jing Li; Juahdi Monbo; Davide Zella; Sergey G Tarasov; Wuyuan Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

View more
  26 in total

1.  MDMX contains an autoinhibitory sequence element.

Authors:  Michal Bista; Miriana Petrovich; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

2.  Autoinhibition of MDMX by intramolecular p53 mimicry.

Authors:  Lihong Chen; Wade Borcherds; Shaofang Wu; Andreas Becker; Ernst Schonbrunn; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

3.  Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.

Authors:  Fan He; Wade Borcherds; Tanjing Song; Xi Wei; Mousumi Das; Lihong Chen; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

4.  Autoactivation of the MDM2 E3 ligase by intramolecular interaction.

Authors:  Qian Cheng; Tanjing Song; Lihong Chen; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2014-05-19       Impact factor: 4.272

5.  Network-based identification of key proteins involved in apoptosis and cell cycle regulation.

Authors:  L Wu; N Zhou; R Sun; X D Chen; S C Feng; B Zhang; J K Bao
Journal:  Cell Prolif       Date:  2014-06-02       Impact factor: 6.831

6.  Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.

Authors:  Xi Wei; Shaofang Wu; Tanjing Song; Lihong Chen; Ming Gao; Wade Borcherds; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

7.  Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.

Authors:  Bin Li; Darren Orton; Leif R Neitzel; Luisana Astudillo; Chen Shen; Jun Long; Xi Chen; Kellye C Kirkbride; Thomas Doundoulakis; Marcy L Guerra; Julia Zaias; Dennis Liang Fei; Jezabel Rodriguez-Blanco; Curtis Thorne; Zhiqiang Wang; Ke Jin; Dao M Nguyen; Laurence R Sands; Floriano Marchetti; Maria T Abreu; Melanie H Cobb; Anthony J Capobianco; Ethan Lee; David J Robbins
Journal:  Sci Signal       Date:  2017-06-27       Impact factor: 8.192

8.  Activating p53 and Inhibiting Superenhancers to Cure Leukemia.

Authors:  Brian Ball; Omar Abdel-Wahab
Journal:  Trends Pharmacol Sci       Date:  2018-12       Impact factor: 14.819

9.  MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.

Authors:  Qingling Huang; Lihong Chen; Leixiang Yang; Xiaoling Xie; Lin Gan; John L Cleveland; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

10.  Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS.

Authors:  Rebekka K Schneider; Vera Ademà; Dirk Heckl; Marcus Järås; Mar Mallo; Allegra M Lord; Lisa P Chu; Marie E McConkey; Rafael Kramann; Ann Mullally; Rafael Bejar; Francesc Solé; Benjamin L Ebert
Journal:  Cancer Cell       Date:  2014-09-18       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.